These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2432418)

  • 1. [Antitoxic properties of monoclonal antibodies against diphtheria toxin].
    Zaĭtsev EM; Sviridov VV; Titova NG; Lebedev VS; Garipova MI
    Mol Gen Mikrobiol Virusol; 1985 Feb; (2):37-41. PubMed ID: 2432418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
    Gupta KC; Agha R; Santos E; Brodeur BR
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxin-neutralizing properties of antibodies to diphtheria toxin recombinant subunits A and B and a new method of their estimation].
    Kaberniuk AA; Oliĭnyk OS; Kolybo DV; Komisarenko SV
    Ukr Biokhim Zh (1999); 2009; 81(3):92-101. PubMed ID: 19877434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.
    Sutjita M; Hohmann A; Comacchio R; Bradley J
    Clin Exp Immunol; 1988 Aug; 73(2):191-7. PubMed ID: 3263226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of monophosphoryl lipid A on antibody response to diphtheria toxin and its subunits.
    Caglar K; Aybay C; Ataoglu H
    APMIS; 2005 Apr; 113(4):256-63. PubMed ID: 15865606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine monoclonal antibodies neutralizing the cytotoxic activity of diphtheria toxin.
    Usuwanthim K; Pootong A; Chaisri U; Tongtawe P; Tapchaisri P; Chongsa-Nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2008 Mar; 26(1):47-55. PubMed ID: 18595529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes.
    Autran B; Triebel F; Viguier M; Jolivet M; Falmagne P; Debre P
    Immunology; 1987 Apr; 60(4):531-8. PubMed ID: 2438207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
    Simpson LL; Lake P; Kozaki S
    J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective monoclonal antibodies to diphtheria toxin.
    Danelli M das G; Teixeira LM; Formiga LC; Peralta JM
    Mem Inst Oswaldo Cruz; 1991; 86(2):265-7. PubMed ID: 1842416
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant.
    Rydell N; Sjöholm I
    Vaccine; 2004 Mar; 22(9-10):1265-74. PubMed ID: 15003656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro determination of antigen quality: biosensor analysis and fluorescence spectroscopy.
    Kersten GF; Jiskoot W; Hazendonk T; Beuvery EC
    Dev Biol Stand; 1998; 92():295-300. PubMed ID: 9554284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies.
    Schoepe H; Wieler LH; Bauerfeind R; Schlapp T; Potschka H; Hehnen HR; Baljer G
    Microb Pathog; 1997 Jul; 23(1):1-10. PubMed ID: 9250775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Production and characteristics of monoclonal antibodies to the diphtheria toxin].
    Valiakina TI; Lakhtina OE; Komaleva RL; Simonova MA; Samokhvalova LV; Shoshina NS; Kalinina NA; Rubina AIu; Filippova MA; Vertiev IuV; Grishin EV
    Bioorg Khim; 2009; 35(5):618-28. PubMed ID: 19915639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.
    Hong HA; Ke NT; Nhon TN; Thinh ND; van der Gun JW; Hendriks JT; Kreeftenberg JG
    Bull World Health Organ; 1996; 74(3):275-82. PubMed ID: 8789926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Properties of monoclonal antibodies interacting with determinants of hepatitis B virus surface antigen].
    Zhdanov VM; Kushch AA; Momot AM; Shumaĭ EP; Anan'ev VA
    Mol Gen Mikrobiol Virusol; 1986 Dec; (12):37-40. PubMed ID: 2433578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of monoclonal antibodies for the determination of diphtheria toxin and its components].
    Sviridov VV; Zaĭtsev EM; Del'vig AA; Mazurova IK; Semenov BF
    Mol Gen Mikrobiol Virusol; 1986 Jan; (1):30-5. PubMed ID: 3537757
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful immunization with a totally synthetic diphtheria vaccine.
    Audibert F; Jolivet M; Chedid L; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1982 Aug; 79(16):5042-6. PubMed ID: 6956913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan.
    McNeela EA; Jabbal-Gill I; Illum L; Pizza M; Rappuoli R; Podda A; Lewis DJ; Mills KH
    Vaccine; 2004 Feb; 22(8):909-14. PubMed ID: 15161067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.